搜尋
Apollomics Inc
APLMW添加自選
0.017USD
-0.003-17.20%
收盤 07/02, 13:00（美東）報價延遲15分鐘
0.00總市值
--本益比TTM
關於 Apollomics Inc 公司
Apollomics Inc. 是一家臨牀階段生物製藥公司，專注於發現和開發腫瘤療法。該公司採用靶向、免疫腫瘤學和其他方法來治療一系列癌症適應症，例如急性髓性白血病、肺癌、腦癌和其他實體腫瘤。其產品線中的候選藥物根據其作用機制分爲三類，每類均包含處於不同開發階段的候選藥物：腫瘤抑制劑、抗癌增強劑和免疫腫瘤藥物。其高級候選藥物是 vebreltinib (APL-101)，這是一種強效、口服、高選擇性 c-Met 抑制劑。其抗癌增強劑候選藥物包括 uproleselan (APL-106)，是一種名爲 E-選擇素的細胞粘附受體的拮抗劑。其免疫腫瘤候選產品包括 APL-501、APL-502、APL-801 和 APL-810。其其他候選產品包括 APL-122、APL-102 和 APL-108。
Apollomics Inc簡介
公司代碼APLMW
公司名稱Apollomics Inc
上市日期Nov 26, 2021
CEODr. Guo-Liang Yu, Ph.D.
員工數量- -
證券類型Company Warrant
年結日- -
公司地址989 East Hillsdale Blvd
城市FOSTER CITY
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編94404
電話16502094055
網址https://www.apollomicsinc.com
公司代碼APLMW
上市日期Nov 26, 2021
CEODr. Guo-Liang Yu, Ph.D.
Apollomics Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Peter K. H. Lin
Mr. Peter K. H. Lin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Yi - Kuei (Alex) Chen
Mr. Yi - Kuei (Alex) Chen
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Mr. Hung-Wen (Howard) Chen
Mr. Hung-Wen (Howard) Chen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Hong-jung (Moses) Chen
Dr. Hong-jung (Moses) Chen
Independent Director
Independent Director
--
--
Dr. Guo-Liang Yu, Ph.D.
Dr. Guo-Liang Yu, Ph.D.
Director
Director
--
--
Dr. Ya-Chi (Claudia) Huang
Dr. Ya-Chi (Claudia) Huang
Independent Director
Independent Director
--
--
Dr. Chen-Huan (Jack) Jan
Dr. Chen-Huan (Jack) Jan
Independent Director
Independent Director
--
--
Mr. Yi-An (Frank) Chu
Mr. Yi-An (Frank) Chu
Independent Director
Independent Director
--
--
Mr. Hsien-Shu Tsai
Mr. Hsien-Shu Tsai
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Peter K. H. Lin
Mr. Peter K. H. Lin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Yi - Kuei (Alex) Chen
Mr. Yi - Kuei (Alex) Chen
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Mr. Hung-Wen (Howard) Chen
Mr. Hung-Wen (Howard) Chen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Hong-jung (Moses) Chen
Dr. Hong-jung (Moses) Chen
Independent Director
Independent Director
--
--
Dr. Guo-Liang Yu, Ph.D.
Dr. Guo-Liang Yu, Ph.D.
Director
Director
--
--
Dr. Ya-Chi (Claudia) Huang
Dr. Ya-Chi (Claudia) Huang
Independent Director
Independent Director
--
--
常見問題
Apollomics Inc的前五大股東是誰？
Apollomics Inc的前五大股東如下：Mr. Peter K. H. Lin